Prognostic value of peripheral blood and bone marrow infiltration assessed by flow cytometry in dogs with de novo nodal peripheral T-cell lymphoma receiving alkylating-rich chemotherapy.

Bone marrow Dog Peripheral T-cell lymphoma Peripheral blood Prognosis

Journal

Veterinary journal (London, England : 1997)
ISSN: 1532-2971
Titre abrégé: Vet J
Pays: England
ID NLM: 9706281

Informations de publication

Date de publication:
10 Dec 2023
Historique:
received: 21 08 2023
revised: 26 11 2023
accepted: 08 12 2023
pubmed: 13 12 2023
medline: 13 12 2023
entrez: 12 12 2023
Statut: aheadofprint

Résumé

Peripheral T-cell lymphoma (PTCL) is highly aggressive in dogs and demonstrates a poor response to traditional chemotherapy. The aim of this retrospective study was to assess the prognostic significance of peripheral blood (PB) and bone marrow (BM) infiltration evaluated by flow cytometry (FC) in dogs with treatment-naïve and histologically confirmed PTCL. To be included, dogs had to undergo complete staging, including FC on lymph nodes, PB and BM samples. Additionally, dogs had to receive an alkylating-rich protocol and have a complete follow-up. Treatment response was evaluated based on RECIST criteria at each chemotherapy session, and the end-staging was conducted at the completion of treatment. Endpoints were time to progression (TTP) and lymphoma-specific survival (LSS). The relationship between TTP/LSS and the percentage of PB and BM infiltration, categorized as > 1%, > 3%, > 5%, > 10%, > 15% and > 20% was investigated. Fifty dogs were included: based on imaging and FC, 78.0% had stage 5 disease, 14.0% had stage 4, 6.0% had stage 3 and 2.0% had stage 1. By multivariable analysis, the CD4-negative phenotype was the only factor associated with a shorter TTP (P = 0.049), while BM infiltration was significantly associated with LSS (P = 0.037). Dogs with BM infiltration > 5% had shorter median LSS (114 days; 95%CI: 0-240) compared to dogs with BM infiltration ≤ 5% (178 days; 95%CI: 145-211). Lack of complete response (P = 0.039) and administration of corticosteroids before chemotherapy (P = 0.026) also significantly worsened LSS. BM flow cytometric evaluation could be considered an essential part of staging work-up for dogs with PTCL and has prognostic relevance.

Identifiants

pubmed: 38086438
pii: S1090-0233(23)00108-9
doi: 10.1016/j.tvjl.2023.106057
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106057

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement None of the authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper.

Auteurs

L Marconato (L)

Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064 Ozzano dell'Emilia, BO, Italy. Electronic address: laura.marconato@unibo.it.

S Comazzi (S)

Department of Veterinary Medical Sciences, University of Milano, Via dell'Università 6, 26900 Lodi, LO, Italy.

C Agnoli (C)

Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064 Ozzano dell'Emilia, BO, Italy.

L Aresu (L)

Department of Veterinary Medical Sciences, University of Torino, Largo P. Braccini 2, 10095 Grugliasco, TO, Italy.

D Stefanello (D)

Department of Veterinary Medical Sciences, University of Milano, Via dell'Università 6, 26900 Lodi, LO, Italy.

F Riondato (F)

Department of Veterinary Medical Sciences, University of Torino, Largo P. Braccini 2, 10095 Grugliasco, TO, Italy.

L Gamberini (L)

Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064 Ozzano dell'Emilia, BO, Italy.

S Sabattini (S)

Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064 Ozzano dell'Emilia, BO, Italy.

Classifications MeSH